Caucasalia macrophylla
Caucasalia macrophylla · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Caucasalia macrophylla is a botanical species that has garnered significant attention within the field of pharmacological research. Recent studies have focused on the therapeutic potential of this plant, particularly in relation to the management of cancer. To explore these medicinal properties, researchers frequently utilize a methanol extract to isolate its bioactive compounds. This specific preparation allows for a concentrated analysis of the plant's chemical constituents and their biological activity. Understanding these mechanisms is a crucial step toward developing new strategies for oncology treatments.
- Synonyms
- Cacalia Caucasica · Adenostyles Macrophylla · 5 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Caucasalia macrophylla is a distinctive plant known by several different names depending on the linguistic context. In certain regions, it is commonly referred to as Аденостилес крупнолистный. It is also frequently identified by the name Кавказалия крупнолистная. Furthermore, the species can be found listed under the common name Крестовник ромболистный. Understanding these various nomenclature variations is essential for accurate botanical identification.
Sources: Catalogue of Life (COL)
Synonyms
Caucasalia macrophylla is a plant species that has been identified through a variety of different botanical names. In scientific literature, it is frequently associated with the synonyms Adenostyles macrophylla and Adenostyles rhombifolia. The plant is also recognized under the names Cacalia caucasica and Cacalia macrophylla. Furthermore, researchers have documented its relationship to the name Cacalia rhombifolia. Understanding these multiple nomenclatural connections is essential for accurate botanical identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Caucasalia macrophylla belongs to the expansive kingdom Plantae, representing a unique branch of the natural world. Within this kingdom, it is classified under the class Equisetopsida, showcasing its fundamental botanical structure. The plant is further categorized into the order Asterales, placing it among a diverse group of flowering species. It falls specifically within the family Asteraceae, a group known for its complex floral arrangements. Finally, its precise biological identity is defined by its membership in the genus Caucasalia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Caucasalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Caucasalia macrophylla is a distinctive plant species primarily found across the temperate regions of Asia. Its natural range extends through the Caucasus and the Transcaucasus, where it thrives in specific local ecosystems. In addition to these mountainous areas, the species is also documented within the western reaches of Asia. Specifically, its presence is noted throughout the diverse landscapes of Türkiye. This widespread yet localized distribution highlights the plant's unique ecological niche within the Eurasian continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Caucasalia macrophylla typically reaches a mature height ranging from 1 meter to a maximum of 1.2 meters. This modest stature makes it a manageable addition to various botanical collections.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Caucasalia macrophylla exhibits significant potential in the treatment of cancer due to its demonstrated cytotoxic activities. Research indicates that the plant's extract effectively treats human breast adenocarcinoma cells, specifically the MDA-MB-231 cell line, by inhibiting cell proliferation. Furthermore, the plant shows measurable effects on hTERT-immortalized mammary epithelial cells (hTERT-HME1) through the modulation of specific miRNA expression profiles. These biological interactions are driven by chemical constituents like rutin, which can target key signaling pathways such as PI3K. Ultimately, the ability of Caucasalia macrophylla to affect both cancer and immortalized cell lines highlights its therapeutic relevance in oncology.
Preparations
Caucasalia macrophylla is prepared as a methanol extract to facilitate comprehensive phytochemical profiling and cytotoxic assessment. This specific extraction method allowed researchers to identify various chemical constituents through the use of GC-MS and HPLC-DAD techniques. The resulting methanol extract was subsequently utilized in MTT assays to evaluate its inhibitory effects on human breast adenocarcinoma cells. Furthermore, the preparation of this extract enabled the investigation of mRNA expression profiles and miRNA-mediated gene regulation. Through this methanol-based preparation, the study successfully identified potent compounds like rutin that demonstrate potential anticancer activity.